Literature DB >> 10527021

The costs of recurrent syncope of unknown origin in elderly patients.

J A Nyman1, A D Krahn, P C Bland, S Griffiths, V Manda.   

Abstract

Although syncope has been shown to reduce quality-of-life, its impact on resource costs has not been documented. The objective of this study was to quantify the annual medical costs of caring for elderly patients with syncope, especially recurrent syncope of unknown origin. Administrative data from the Health Care Financing Administration were obtained on 7,959 Medicare patients who had at least one inpatient admission with a diagnosis of syncope in 1993. The costs of any inpatient admissions, outpatient procedures, or physician visits with an ICD-CM-9 diagnosis for syncope were summed for a 365-day period from the date of the initial hospitalization for syncope. Patients who had at least two hospitalizations with admission and discharge diagnosis of syncope were deemed to have recurrent syncope of uncertain origin. To better estimate syncope costs for those whose syncope costs could have been attributed to other diagnoses, a regression analysis was performed including variables representing the most frequent secondary diagnoses. The average annual costs of those who were admitted with syncope but who were discharged with another diagnosis was $4,942 in 1993. The average annual cost of patients with recurrent syncope deemed to be of unknown origin was $5,165. For those patients with secondary diagnoses of atherosclerosis, urinary tract infections, or hypokalemia, the annual costs of syncope averaged $6,820, $7,013, or $7,949, respectively.

Entities:  

Mesh:

Year:  1999        PMID: 10527021     DOI: 10.1111/j.1540-8159.1999.tb00633.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  6 in total

1.  Testing in syncope.

Authors:  Shamai A Grossman
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

2.  The ACCF/AHA scientific statement on syncope: a document in need of thoughtful revision.

Authors:  D G Benditt
Journal:  Clin Auton Res       Date:  2006-09-29       Impact factor: 4.435

3.  Transient loss of consciousness assessment in a University Hospital: From diagnosis to prognosis.

Authors:  Mariana Silva; Ana Godinho; João Freitas
Journal:  Porto Biomed J       Date:  2016-08-25

4.  Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of "community acquired" syncope.

Authors:  Jeffrey S Hoch; Marie Antoinette Rockx; Andrew D Krahn
Journal:  BMC Health Serv Res       Date:  2006-06-06       Impact factor: 2.655

5.  Using the Boston Syncope Observation Management Pathway to Reduce Hospital Admission and Adverse Outcomes.

Authors:  Oren J Mechanic; Celine Y Pascheles; Gregory J Lopez; Alina M Winans; Nathan I Shapiro; Carrie Tibbles; Richard E Wolfe; Shamai A Grossman
Journal:  West J Emerg Med       Date:  2019-02-04

6.  Predicting adverse outcomes in syncope.

Authors:  Shamai A Grossman; Christopher Fischer; Lewis A Lipsitz; Lawrence Mottley; Kenneth Sands; Scott Thompson; Peter Zimetbaum; Nathan I Shapiro
Journal:  J Emerg Med       Date:  2007-07-05       Impact factor: 1.484

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.